Total submissions: 2
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Labcorp Genetics |
RCV001980875 | SCV002286685 | uncertain significance | Glycogen storage disease due to muscle and heart glycogen synthase deficiency | 2022-08-16 | criteria provided, single submitter | clinical testing | This sequence change results in a frameshift in the GYS1 gene (p.Pro722Argfs*120). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 16 amino acid(s) of the GYS1 protein and extend the protein by 103 additional amino acid residues. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with GYS1-related conditions. ClinVar contains an entry for this variant (Variation ID: 1492332). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
| Gene |
RCV004774592 | SCV005384034 | uncertain significance | not provided | 2023-12-28 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); Frameshift variant predicted to result in abnormal protein length as the last 16 amino acids are replaced with 119 different amino acids; Has not been previously published as pathogenic or benign to our knowledge |